Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
50
pubmed:dateCreated
2004-12-15
pubmed:abstractText
We identify a human mutation (E1053K) in the ankyrin-binding motif of Na(v)1.5 that is associated with Brugada syndrome, a fatal cardiac arrhythmia caused by altered function of Na(v)1.5. The E1053K mutation abolishes binding of Na(v)1.5 to ankyrin-G, and also prevents accumulation of Na(v)1.5 at cell surface sites in ventricular cardiomyocytes. Ankyrin-G and Na(v)1.5 are both localized at intercalated disc and T-tubule membranes in cardiomyocytes, and Na(v)1.5 coimmunoprecipitates with 190-kDa ankyrin-G from detergent-soluble lysates from rat heart. These data suggest that Na(v)1.5 associates with ankyrin-G and that ankyrin-G is required for Na(v)1.5 localization at excitable membranes in cardiomyocytes. Together with previous work in neurons, these results in cardiomyocytes suggest that ankyrin-G participates in a common pathway for localization of voltage-gated Na(v) channels at sites of function in multiple excitable cell types.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11053140, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11273715, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11410597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11724816, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11786529, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11796721, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11891345, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11901046, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-11972032, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12478303, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12480819, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12571597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12657669, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12716895, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-12829783, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-14597261, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-14757759, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-15042347, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-2560390, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-8989112, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-9572267, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-9664041, http://linkedlifedata.com/resource/pubmed/commentcorrection/15579534-9832557
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17533-8
pubmed:dateRevised
2011-7-22
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
pubmed:affiliation
Howard Hughes Medical Institute and Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA. peter.j.mohler@vanderbilt.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't